Complexo Hospitalario Universitario de Pontevedra
Centro asistencial
Clínica Universitaria de Navarra
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (21)
2024
-
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810
-
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)
Journal of the European Academy of Dermatology and Venereology
2023
-
Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 227-237
-
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296
2021
-
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)
Acta dermato-venereologica, Vol. 101, Núm. 11, pp. adv00602
2020
-
The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain
Scientific Reports, Vol. 10, Núm. 1
2019
-
Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Actas Dermo-Sifiliograficas, Vol. 110, Núm. 6, pp. 448-459
-
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 556-571
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
HTLV-1 infection in solid organ transplant donors and recipients in Spain
BMC Infectious Diseases, Vol. 19, Núm. 1
2017
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)
Journal of Viral Hepatitis, Vol. 24, Núm. 9, pp. 725-732
-
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Hepatology, Vol. 65, Núm. 6, pp. 1810-1822
2014
-
Frontal fibrosing alopecia: A multicenter review of 355 patients
Journal of the American Academy of Dermatology, Vol. 70, Núm. 4, pp. 670-678
-
The Use of systematic reviews in clinical trials and narrative reviews in dermatology: Is the best evidence being used?
Actas Dermo-Sifiliograficas, Vol. 105, Núm. 3, pp. 295-299
-
Tratamiento de las ictiosis congénitas
Piel, Vol. 29, Núm. 1, pp. 43-48
2013
-
Prevalence of dystrophic epidermolysis bullosa in Spain: A population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care
Actas Dermo-Sifiliograficas, Vol. 104, Núm. 10, pp. 890-896
-
Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: Where should research direct to? an example of priority setting partnership in very rare disorders
Orphanet Journal of Rare Diseases, Vol. 8, Núm. 1
2009
-
Cortical atrophy and language network reorganization associated with a novel progranulin mutation
Cerebral Cortex, Vol. 19, Núm. 8, pp. 1751-1760
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229